Trending

#COYA

Latest posts tagged with #COYA on Bluesky

Latest Top
Trending

Posts tagged #COYA

Video

Haven't been to a #cafc away game since the days of Bowyer. Disciplined performance yesterday at Southampton spurred on by great support #coya

0 0 0 0
Post image

Houston biotech co. raises $11M to advance ALS drug development Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment ...

#Coya #Dr. #reddy’s #laboratories #inc […]

[Original post on houston.innovationmap.com]

0 0 0 0
Post image

Houston biotech co. raises $11M to advance ALS drug development Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment ...

#Coya #Dr. #reddy’s #laboratories #inc […]

[Original post on houston.innovationmap.com]

0 0 0 0
Post image

Houston biotech co. raises $11M to advance ALS drug development Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment ...

#Coya #Dr. #reddy’s #laboratories #inc […]

[Original post on houston.innovationmap.com]

0 0 0 0
Post image

Houston biotech co. raises $11M to advance ALS drug development Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment ...

#Coya #Dr. #reddy’s #laboratories #inc […]

[Original post on houston.innovationmap.com]

0 0 0 0
Post image

Houston biotech co. raises $11M to advance ALS drug development Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment ...

#Coya #Dr. #reddy’s #laboratories #inc […]

[Original post on houston.innovationmap.com]

0 0 0 0
Preview
[Video] Captura de alias ‘Coya’ refuerza alerta por presencia del crimen transnacional en Antioquia Frente a estos hechos, CORPADES advirtió que Medellín y el Oriente antioqueño se han consolidado como zonas de refugio, descanso y operación de la Delincuencia Organizada Transnacional (DOT).

#Panameño | #Coya | #OrienteAntioqueño | #Colombia 🇨🇴 🔴

CORPADES alertó además que, pese a los operativos de alto impacto y las capturas recientes, la presencia de mafias de origen mexicano, europeo, estadounidense, asiático...

analisisurbano.org/video-captur...

0 0 0 0

Can't believe there was even a debate about whether that was red or not. #coya

1 0 0 0

Ange really has to start taking responsibility for all these injuries. #coya

9 0 0 0
Post image

Get a flick through the Tonbridge Angels vs Crystal Palace football programme from 1998 scanned in full into Flickr

Click on the link below to read and enjoy

#TonbridgeAngels #COYA #CrystalPalace #CPFC

www.flickr.com/photos/11405...

2 1 1 0
Preview
Coya Therapeutics Advances Phase 2 ALS Program with Health Canada CTA Acceptance Coya Therapeutics, Inc. (NASDAQ: COYA) announced that Health Canada has accepted, without objection, the Clinical Trial Application (CTA) for COYA 302, enabling

#COYA
Coya Therapeutics advances its Phase 2 ALS program with Health Canada CTA acceptance for COYA 302, enabling patient enrollment in Canada and expanding the ongoing ALSTARS trial alongside U.S. sites.
#CoyaTherapeutics
prismmarketview.com/coya-therape...

0 0 0 0
Post image

Yá veréis cómo-yos toquen lo que nun suena, porque como siempres diximos, les alministraciones asturianes quieren velos desaniciaos.
#horru #panera #cabazo #Coya #Piloña #Asturies

2 2 0 1
Preview
Coya Therapeutics Kicks Off Phase 2 ALSTARS Dosing for COYA 302, Triggering $4.2M Milestone Payment Coya Therapeutics (Nasdaq: COYA) announced that patients have now been dosed in the ALSTARS Trial, the company’s Phase 2 study evaluating COYA 302 for the tre

Coya Therapeutics #COYA has started dosing ALS patients in the Phase 2 ALSTARS Trial of COYA 302, unlocking a 4.2M dollar milestone payment.
A meaningful step for this investigational therapy and the ALS community.
prismmarketview.com/coya-therape...

0 0 0 0
Post image

Check out this story in Biospace profiling End the Legacy co-founder and current Coya team member Daniel Barvin.
www.biospace.com/drug-development/coya-ex...

#endthelegacy #c9orf72 #coya

0 0 0 0
Preview
Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock Coya Therapeutics (NASDAQ: COYA) priced an underwritten public offering of 3,636,364 shares of common stock at $5.50 per share, with gross proceeds expected to be approximately $20.0 million. The company granted the underwriter a 30-day option to purchase up to 545,454 additional shares at the offering price, subject to underwriting discounts and commissions.The offering is expected to close on or about October 27, 2025, subject to customary closing conditions. Net proceeds are intended for working capital and general corporate purposes, including funding Coya's clinical development plan. The shares are offered under a Form S-3 shelf registration declared effective August 19, 2025.

#COYA Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0
Preview
Coya Therapeutics Announces Proposed Public Offering of Common Stock Coya Therapeutics (NASDAQ: COYA) announced a proposed underwritten public offering of common stock on October 23, 2025.The offering may include a 30-day underwriter option to purchase up to an additional 15% of the shares at the offering price, less discounts and commissions. Proceeds are intended for working capital and clinical development. Lucid Capital Markets is sole book-running manager.The offering is being made under a shelf registration statement on Form S-3 (File No. 333-289511) declared effective by the SEC on August 19, 2025; final terms will be disclosed in a prospectus supplement and are subject to market and other conditions.

#COYA Coya Therapeutics Announces Proposed Public Offering of Common Stock

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0
Preview
Coya Therapeutics Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral Sclerosis The ALSTARS Trial is a well powered randomized, multi-center, double-blind, placebo-controlled, 24- week study of COYA 302 in people with Amyotrophic Lateral Sclerosis. The ALSTARS Trial will enroll 120 ALS participants at approximately 25 centers in the United States and Canada. HOUSTON, Sept. 22, 2025/ PRNewswire/-- Coya Therapeutics, Inc., a clinical-stage...

#COYA Coya Therapeutics Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral Sclerosis

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0
Post image

Esteban Pérez Vigil nacido en Coya en 1892, emigró a La Habana donde logró enriquece. Encargó en 1930 a un carpintero local y suegro suyo la construcción en la aldea de La #VillaBaxu #Coya #Piloña, #Asturias de esta quinta
Acabada en 1934 hoy es un atractivo hotel al que rodea un entorno muy cuidado

5 1 0 0
Post image

#COYA
#CoyaTherapeutics, Inc. announced its Phase 2 COYA 302 ALS trial has been accepted as a NEALS-Affiliated Trial. Following recent FDA IND clearance, the study is expected to begin in Q4 2025 and will be presented during a NEALS webinar later this month.
prismmarketview.com/coya-therape...

0 0 0 0
Preview
Coya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial NEALS, the world's largest ALS research consortium, has selected the COYA 302 trial and it is now affiliated with NEALS as part of its mission to accelerate the development of new treatments for people living with ALS;. Following FDA's recent acceptance of the COYA 302 IND, Coya plans to initiate its Phase 2 study in people with ALS in Q4 2025;. HOUSTON, Sept. 4, 2025/...

#COYA Coya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0
Post image

(NASDAQ: #COYA)
#CoyaTherapeutics announced FDA acceptance of its IND for COYA 302 in ALS, clearing the way for a Phase 2 trial. The milestone also triggers a $4.2M payment from partner Dr. Reddy’s, reinforcing the strategic path forward in neurodegeneration.
prismmarketview.com/coya-therape...

0 0 0 0
Preview
Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Coya Therapeutics (NASDAQ:COYA) has received FDA acceptance of its Investigational New Drug (IND) application for COYA 302, a proprietary immunomodulatory biologic combination therapy for treating Amyotrophic Lateral Sclerosis (ALS). The acceptance enables the company to proceed with a Phase 2 multicenter, double-blind, placebo-controlled clinical study to evaluate the treatment's efficacy and safety.The milestone triggers a $4.2 million payment to Coya from its partner Dr. Reddy's Laboratories (DRL). The development represents a significant step in Coya's partnership with DRL to advance potential treatments for ALS patients.

#COYA #RDY Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0
Video

Zooming slime friend

#gamedev #indiedev #gamemaker #roguelike #roguelite #coya

10 5 0 0
Preview
Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update HOUSTON, Aug. 12, 2025/ PRNewswire/-- Coya Therapeutics, Inc., a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell function in patients with neurodegenerative disorders, provides a corporate update and announces its financial results for the quarter ended June 30, 2025.. It was published in the scientific...

#COYA Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0

I’m a Charlton fan and your post reached me. Congrats on that. #coya

1 0 0 0
Preview
New Research Reveals Critical Inflammation Pathway in Parkinson's Disease, Potential Treatment Breakthrough Novel study uncovers key inflammatory mechanisms in Parkinson's progression, supporting development of innovative dual-action therapy. See groundbreaking results.

#COYA Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson’s Disease

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0
This painting is one of a series of sixteen at the Denver Art Museum in Denver Colorado showing ancient rulers of the Inca Empire. It is not only a family tree but a political tool. Since proof of aristocratic Inca blood entitled people to special privileges and freed them from paying taxes in the Spanish Colonial period, paintings were used to document and assert this heritage. The set of paintings ends with Francisco Pizarro, the Spanish “conqueror” of Peru in 1534, shown in his European armor.

Although romanticized, the Inca male rulers wear the uncu, an exquisitely woven tunic, and an aberrant version of the llautu, the traditional royal headdress complete with red forehead fringe. The painting of the Inca queen, Mama Occollo, shows her wearing the traditional women’s mantle, or lliclla, a rectangular cloth worn across the shoulders so that the stripes appear horizontally across the back, and held in place by a tupu pin inserted horizontally in the front. The geometric textile patterns in all the paintings are reminiscent of tocapu designs on traditional Inca noble clothing, signifying rank and status.

The Coya Mama Ocllo Coya (or just Mama Ocllo) was a princess and queen consort, Coya, of the Inca Empire by marriage to her younger brother, Sapa Inca Topa Inca Yupanqui in accordance with custom. She was the mother of Huayna Capac and Coya Cusirimay. Queen Mama Ocllo is described as a dominant figure, "desirous for wealth" and remembered for her stratagems by which she was to have wielded great influence upon the affairs of state. 

After the death of her spouse, Topa Inca Yupanqui, in 1493, her son and heir, Huayna Capac, was still a minor. The favorite concubine of her late spouse, Ciqui Ollco, attempted to place her son Capac Huari on the throne. Queen dowager Mama Ocllo prevented this attempted coup by planting the rumor that Ciqui Ollco was a witch and exiling Capac Huari to Chincheru, while her son, Huayna Capac, became the next Inca leader.

This painting is one of a series of sixteen at the Denver Art Museum in Denver Colorado showing ancient rulers of the Inca Empire. It is not only a family tree but a political tool. Since proof of aristocratic Inca blood entitled people to special privileges and freed them from paying taxes in the Spanish Colonial period, paintings were used to document and assert this heritage. The set of paintings ends with Francisco Pizarro, the Spanish “conqueror” of Peru in 1534, shown in his European armor. Although romanticized, the Inca male rulers wear the uncu, an exquisitely woven tunic, and an aberrant version of the llautu, the traditional royal headdress complete with red forehead fringe. The painting of the Inca queen, Mama Occollo, shows her wearing the traditional women’s mantle, or lliclla, a rectangular cloth worn across the shoulders so that the stripes appear horizontally across the back, and held in place by a tupu pin inserted horizontally in the front. The geometric textile patterns in all the paintings are reminiscent of tocapu designs on traditional Inca noble clothing, signifying rank and status. The Coya Mama Ocllo Coya (or just Mama Ocllo) was a princess and queen consort, Coya, of the Inca Empire by marriage to her younger brother, Sapa Inca Topa Inca Yupanqui in accordance with custom. She was the mother of Huayna Capac and Coya Cusirimay. Queen Mama Ocllo is described as a dominant figure, "desirous for wealth" and remembered for her stratagems by which she was to have wielded great influence upon the affairs of state. After the death of her spouse, Topa Inca Yupanqui, in 1493, her son and heir, Huayna Capac, was still a minor. The favorite concubine of her late spouse, Ciqui Ollco, attempted to place her son Capac Huari on the throne. Queen dowager Mama Ocllo prevented this attempted coup by planting the rumor that Ciqui Ollco was a witch and exiling Capac Huari to Chincheru, while her son, Huayna Capac, became the next Inca leader.

Mama Ocllo Huacco I Ccoya del Peru - After Marco Chillitupa Chávez (Peruvian) - Oil on canvas / 1830-1850 - Denver Art Museum (Colorado) #WomenInArt #art #ArtText #artwork #DenverArtMuseum #PeruvianArt #Queen #Peruvian #womensart #portraitofawoman #oilpainting #MamaOcllo #incan #coya #blueskyart

46 6 0 0
Come Over Your Auntie Q&A Pt.3 | Is it a Drama? Why is it important? | Camden Fringe
Come Over Your Auntie Q&A Pt.3 | Is it a Drama? Why is it important? | Camden Fringe YouTube video by Henri-Koschei The Rex System

Q&A with the Writer; Pt.3!

This time with my shirt off! (Almost!)

Come Over Your Auntie
@camdenfringe
Rosemary Branch Theatre & Pub
28th-30th July
7pm Nightly, £8 Tickets

#ComeOverYourAuntie #ComeOverYourAuntieShow #COYA #GillyTuppence #Comedy #DarkComedy

youtu.be/fc60cb4bzDo?...

0 1 0 1
Preview
Come Over Your Auntie - Camden Fringe Join Agony Aunt, Gilly Tuppence, as she finally brings her Radio Show to a Live Studio Audience! A one (wo)man Character Comedy Show pushing the limits of satire, whilst exploring the depths of dark c...

camdenfringe.com/events/come-...

#ComeOverYourAuntie #ComeOverYourAuntieShow #COYA #GillyTuppence #Comedy #DarkComedy #CharacterComedy #ComedyCharacter #SketchComedy #SkitComedy #JuliaDavis #NightyNight #AlanPartridge #TheLeagueOfGentlemen #London #RosemaryBranch #RosemaryBranchTheatre #Fringe

0 1 0 0
Preview
Coya's Exclusive Patent Win Strengthens IL-2 Drug Pipeline as Phase 2b ALS Trial Approaches New USPTO patent grants Coya exclusive rights for stable IL-2 formulations. See how this impacts their ALS treatment timeline and drug development pipeline. Learn more.

#COYA Coya Therapeutics Announces Issuance of New U.S. Patent Protecting Methods of Producing Recombinant Human (rh) Interleukin-2 (aldesleukin) Liquid Formulations

www.stocktitan.net/news/COYA/coya-therapeut...

0 0 0 0